Global Law Office is one of the ‘Outstanding’ firms in banking and finance. The firm’s banking and finance team has extensive experience in onshore, offshore and cross-border financing work, covering bilateral and syndicated loans, project finance, acquisition finance, real estate finance, asset finance, trade and ECA-backed finance. Lawrence Lin leads the firm’s banking and finance team. The firm’s private equity team got a further boost with the hiring of six partners in the last 12 months.
Client feedback
“Professional.” – Competition/antitrust
“Practical approach instead of theoretical analysis, timely response, understanding of business environment and solution-driven attitude.” – Corporate and M&A
“Provide professional advice on the litigation and they do it very well.” – Dispute resolution
“Their team's dedication, solution-driven attention to detail and professionalism in handling sensitive issues have left a lasting impression on me.” – Dispute resolution
“GLO worked as the lawyer of CPE, and mostly achieved CPE's initial goal.” – Dispute resolution
“They are efficient and professional. They always help us to solve the problems in time.” – Investment funds
“GLO lawyers are very knowledgeable and experienced in fund management and media and entertainment practices. They have been very efficient and responsive to our requests. In particular, with industrial knowledge in media and entertainment industry, GLO is able to not only assist us in identifying legal risks and providing effective legal solutions but also is able to advise us on the business side. Also, GLO lawyers, including their partners, are very easy to communicate with, patient and hard-working.” – Investment funds
“Professional and efficient transaction service.” – Private equity
“Global Law Office excels in providing professional advice and customer communication. The firm always provides opinions that best meet legal and regulatory requirements while meeting customer needs from a compliance perspective. We are very satisfied with Global Law Office's professional and timely feedback.” – Regulatory
Jia Gui
“Always able to provide professional advice and give feedback immediately. One of the best lawyers I used to work together.”
Shifang Guo
“Commercial insights and good communication.”
Zhao Li
“He's very responsive and result-oriented and focuses on the litigation strategies to achieve the client's goals.”
Jerry Liu
“Jerry is very professional and always provides legal advice and solutions to clients in a timely manner. He is also humorous and knowledgeable.”
Xianlai Liu
“He is an expert in investment fund and private equity areas. He can give us professional and one-stop services.”
Shujun Liu
“Apart from general legal issues, she is very skilled in antitrust-related business. For us, she is a very outstanding and indispensable partner.”
Zhiping Zhu
“He is able to comprehensively control legal risks for clients from the perspectives of investment, transaction structure design and project prospect based on his deep understanding of rules and business models of the entertainment industry and integration and coordination of various resources.”
Work highlights
Advised National Council for Social Security Fund on its strategic investment in COFCO Fortune.
Advised Changjiang Securities Innovation Investment on its investment in Qinghai Lihao Semiconductor’s Series B round of financing.
Advised Hidden Hill Capital on its participation in Geely's Farizon Auto's pre-A round of financing.
Advised investors including MSD and IDG Capital on their participation in Sichuan Kelun Biotech’s Series B round of financing.
Advised Hidden Hill Capital and two other market-leading investors on their participation in SANY Heavy Truck's Series A round of financing.
Key clients
Jiangsu Hanbon Science and Technology, MiHoYo Technology, Shunwei Capital, Xiaomi Corporation, Xiaomi Industry Fund, Yuanxi Information Technology.
Work highlights
Represented Perfect World in a trademark infringement case against an online game company.
Represented Tsinghua University and Nuctech Company in a series of IP infringement cases against Beijing Juhe Xinda Technology.
Key clients
Jemincare Group, Sichuan Kelun Botai Biopharmaceutical, T.Gstar
Work highlights
Represented Zhongzhi Enterprise Group and its subsidiaries, a Chinese leading asset management group, in a series of disputes against Zhejiang Tianma Bearing Group.
Assisting China National Light Industrial Products Import and Export Group in series of cases triggered by foreign and domestic transactions of various business models and trade-related warehousing matters.
Represents a well-known trust company in handling a dispute regarding the transfer of the creditor’s right.
Key clients
Guangzhou Peggy Foods Company, Sartorius, Zhuhai Meizu Communication Equipment.
Work highlights
Advised Jiangxi Copper Hong Kong Company on its investment to the fund CCBT Global Navigation Fund managed by CMB Wing Lung Asset Management.
Advised China Life Insurance Company on the establishment of the China-LOGOS logistics investment fund.
Key clients
China Culture Industrial Investment Fund, Cloudview Capital, Eastern Bell Capital, Yuantaibaoman (Suzhou) Equity Investment Management.
Work highlights
Acted for Primavera Capital Group on its $2.2 billion acquisition of the greater China business of Mead Johnson, a famous premium infant milk formula brand, from Reckitt Benckiser Group.
Advised on the privatisation of New Frontier Health Corporation.
Advised Shenzhen SF Taisen Holdings on its acquisition of Kerry Logistics, a Hong Kong-listed company, through a wholly owned subsidiary through tender offer, with an investment of about HK$18 billion ($2.3 billion).
Key clients
Ascentage Pharma, Jiaxin International Resources Investment, Shanghai Medical Instruments, Xiaomi Corporation.
Work highlights
Advised MultiMetaVerse on its de-SPAC merger with Model Performance Acquisition Corp. Upon completion of the merger, the resulting combined company became MultiMetaVerse Holdings.
Advised Asian Infrastructure Investment Bank on the issuance of 2022 RMB Bonds Series 1 sustainable development bonds with an amount of Rmb1.5 billion.
Advised Jadard Technology on its IPO on the STAR Market.
Advised Mexin Yishen Machinery's listing on the National Equities Exchange and Quotations.
Advised Xi'an High Voltage Apparatus Research Institute on its listing on the STAR Market.
Key clients
AustAsia Group, GLP China Holdings, Mercedes-Benz International Finance, Prime Number Capital.
Work highlights
Assisted Haitong UniTrust, Sumitomo Mitsui Bank, CITIC Bank, CMB Wing Lung Bank, E.SUN Bank and Bank of China to sign an ESG-linked syndicated loan agreement for Rmb1 billion ($137 million).
Acted as the PRC counsel to the deal for International Finance Corporation’s lending to New China Water (Nanjing).
Acted as the PRC counsel of the lenders for a series of loan financings to the offshore subsidiaries of Lygend Resources & Technology.
Key clients
Bank of China, Chong Hing Bank, DJ New Ease Group, Huaxia Financial Leasing.
Work highlights
Advised Shanghai Taopu Smart City on the Taopu central green space phase II project.
Advised Beijing Infrastructure Investment on the establishment of Beijing Suburban Railway Joint Development Group.
Advised Beijing Maglev Transportation Development on the construction of the S1 Line in Beijing.
Key clients
Beijing BII Traffic Development, Beijing Infrastructure Investment, Qingdao Haifa State-owned Capital Investment and Operation Group, Shanghai Fengqin Real Estate.
Work highlights
Contributed to the writing and editing of the Corporate Compliance Officer Textbook led by the China Council for the Promotion of International Trade Commercial Legal Services Centre.
Assisted Boehringer-Ingelheim with dozens of internal investigation cases.
Advised Jiangsu Yaomaitong Medical Technology on the introduction of ISO 37001:2016 Anti-bribery Management Systems, and the establishment of an anti-bribery management system.
Advised Newrizon Motor on data and personal information protection and compliance.
Key clients
China Pharmaceutical Industry Association, GenSci, Hengrui Pharmaceuticals.
